-
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-contr
(Hinzugefügt: 29.12.2021 um 15:56 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02753-7/fulltext
-
Clinical trials approved for CanSino’s inhaled COVID-19 vaccine
(Hinzugefügt: 24.03.2021 um 09:04 Uhr)
https://www.globaltimes.cn/page/202103/1219242.shtml
-
China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary
(Hinzugefügt: 22.03.2021 um 07:27 Uhr)
https://www.reuters.com/article/health-coronavirus-cansinobio-hungary-idUSL4N2LK02H
-
China’s CanSino COVID-19 vaccine shows 75% efficacy in Pakistan
(Hinzugefügt: 10.02.2021 um 09:45 Uhr)
https://gulfnews.com/world/asia/pakistan/chinas-cansino-covid-19-vaccine-shows-75-efficacy-in-pakistan-1.77072312
-
Third Chinese Covid-19 Vaccine Was 66% Effective in Late-Stage Study
(Hinzugefügt: 09.02.2021 um 09:16 Uhr)
https://www.wsj.com/articles/third-chinese-covid-19-vaccine-was-66-effective-in-late-stage-study-11612800486
-
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
(Hinzugefügt: 04.02.2021 um 09:37 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext
-
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
(Hinzugefügt: 04.02.2021 um 09:37 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext
-
3 Impfstoffe aus China drängen auf weltweiten Einsatz
(Hinzugefügt: 04.02.2021 um 09:24 Uhr)
https://www.aerzteblatt.de/nachrichten/120839/3-Impfstoffe-aus-China-draengen-auf-weltweiten-Einsatz
-
China CanSinoBIO's COVID-19 vaccine trials recruit over 20,000 people
(Hinzugefügt: 22.12.2020 um 13:09 Uhr)
https://www.reuters.com/article/us-health-coronavirus-vaccine-cansinobio-idUSKBN28V1N8